HIGHFDA DRUG

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Chemical contamination; presence of lead and lithium above specification

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
April 20, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
April 20, 2026
Hazard Level
HIGH
Brands
NAPROXEN, Acella Pharmaceuticals, LLC
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
NAPROXEN, Acella Pharmaceuticals, LLC
Model numbers
Lot: 23F02, Expires: 05/2026, 25A37, Expires: 01/2028.
UPC codes
42192-619, 42192-619-16
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    April 20, 2026

  2. Reported by FDA DRUG

    May 13, 2026

  3. RecallRadar source check

    May 20, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Chemical contamination; presence of lead and lithium above specification

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Acella Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for NAPROXEN recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16. Generic: NAPROXEN; Brand: NAPROXEN. Reason: Chemical contamination; presence of lead and lithium above specification. Classification: Class II. Quantity: 6,336 bottles. Distribution: Nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot: 23F02
Expires: 05/2026
25A37
Expires: 01/2028.
UPC Codes
42192-619
42192-619-16
Affected States
ALL
Report Date
May 13, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE